Lisa Graver

Lisa Graver

Chief Executive Officer at ALVOTECH

Net worth: 117 143 $ as of 30/06/2026

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Currently, Lisa Graver is Chief Executive Officer at Norwich Pharmaceuticals, Inc., Chief Executive Officer at Alvotech starting in 2026, and Director at Alvotech hf.
Formerly, Ms. Graver was Chief Executive Officer at Alvogen, Inc. from 2010 to 2025, Chief Executive Officer at Alvogen Pharma US, Inc., Senior Director & VP-Intellectual Property at Actavis, Inc. from 2006 to 2008, Associate at Kirkland & Ellis LLP, and President at Almaject, Inc. Education includes undergraduate studies at the University of Lakehead and graduate studies at Case Western Reserve University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/03/2026 31,746 ( 0.01% ) 117 143 $ 30/06/2026

Lisa Graver active positions

CompaniesPositionStart
ALVOTECH Chief Executive Officer 01/03/2026
Chief Executive Officer -
Director/Board Member -

Former positions of Lisa Graver

CompaniesPositionEnd
Chief Executive Officer 01/12/2025
Chief Executive Officer 01/12/2025
Corporate Officer/Principal 01/01/2008
President -
Corporate Officer/Principal -
See the detail of Lisa Graver's experience

Training of Lisa Graver

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

20

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology